MIP and neoplasm: This was consistent with our observation in the ex-vivo DC suppression assay where the IFNR1-/- DCs even after MIP treatment, significantly suppressed the proliferation of tumor specific T cells induced by the immunocompetent tumor pulsed BMDCs.